In vitro and in vivo inhibition of glucocorticoid-induced osteoporosis by the hexane extract of Poncirus trifoliata

Phytotherapy Research

Volumn 25, Issue 7, 2011, Pages 1000-1010

  Kim, Bo Young ^a   Yoon, Hyung Young ^a   Yun, Sun Il ^a   Woo, Eun Rhan ^b   Song, Nan Kyu ^c   Kim, Hyun Gyu ^c   Jeong, Seon Yong ^a   Chung, Yoon Sok ^a  

^a Ajou University School of Medicine   (South Korea)

^b Chosun University   (South Korea)

^c HL Genomics Co Ltd   (South Korea)

Author keywords

Annexin A6; Differentially expressed gene; Glucocorticoids; Mice; Osteoporosis; Poncirus trifoliata

Indexed keywords

CALPHOBINDIN II; COLLAGEN TYPE 6; COLLAGEN TYPE 6 ALPHA 2; GLUCOCORTICOID ANTAGONIST; HEXANE; MESSENGER RNA; PLANT EXTRACT; PONCIRUS TRIFOLIATA EXTRACT; STRONTIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANNEXIN A6 GENE; APOPTOSIS; ARTICLE; CELL DEATH; CELL VIABILITY; COLLAGEN TYPE 6 ALPHA 2 GENE; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIFOLIATE ORANGE; WESTERN BLOTTING;

ANIMALS; ANNEXIN A6; APOPTOSIS; CELL LINE; DEXAMETHASONE; GLUCOCORTICOIDS; MALE; MICE; MICE, INBRED ICR; OSTEOBLASTS; OSTEOGENESIS; OSTEOPOROSIS; PLANT EXTRACTS; PONCIRUS;

MUS; PONCIRUS TRIFOLIATA; RUTACEAE;

EID: 84860389514     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3373     Document Type: Article

References (45)

1. Alesci S, De Martino MU, Ilias I et al. 2005. Glucocorticoid-induced osteoporosis: from basic mechanisms to clinical aspects. Neuroimmunomodulation 12:1-19. (Pubitemid 40528906)
2. Angeli A, Guglielmi G, Dovio A et al. 2006. High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone 39:253-259. (Pubitemid 43870263)
3. Bonura F. 2009. Prevention, screening, and management of osteoporosis: an overview of the current strategies. Postgrad Med 121:5-17.
4. Cabrera WE, Schrooten I, De Broe ME et al. 1999. Strontium and bone. J Bone Miner Res 14:661-668. (Pubitemid 29210591)
5. Caichompoo W, Zhang QY, Hou TT et al. 2009. Optimization of extraction and purification of active fractions from Schisandra chinensis (Turcz.) and its osteoblastic proliferation stimulating activity. Phytother Res 23:289-292.
6. Canalis E, Delany AM. 2002. Mechanisms of glucocorticoid action in bone. Ann N YAcad Sci 966:73-81. (Pubitemid 34729163)
7. Canalis E, Mazziotti G, Giustina A et al. 2007. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18:1319-1328. (Pubitemid 47389469)
8. Chen NX, O'Neill KD, Chen X et al. 2008. Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells. J Bone Miner Res 23:1798-1805.
9. Dieudonne SC, Kerr JM, Xu T et al. 1999. Differential display of human marrow stromal cells reveals unique mRNA expression patterns in response to dexamethasone. J Cell Biochem 76:231-243. (Pubitemid 30030771)
10. Gudbjornsson B, Juliusson UI, Gudjonsson FV. 2002. Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice. Ann Rheum Dis 61:32-36. (Pubitemid 34074836)
11. Ha H, Ho J, Shin S et al. 2003. Effects of Eucommiae Cortex on osteoblast-like cell proliferation and osteoclast inhibition. Arch Pharm Res 26:929-936.
12. Haag J, Aigner T. 2007. Identification of calponin 3 as a novel Smad-binding modulator of BMP signaling expressed in cartilage. Exp Cell Res 313:3386-3394. (Pubitemid 47404559)
13. Heino TJ, Chagin AS, Sävendahl L. 2008. The novel estrogen receptor G-protein-coupled receptor 30 is expressed in human bone. J Endocrinol 197:R1-R6. (Pubitemid 351696258)
14. Jayaprakasha GK, Mandadi KK, Poulose SM et al. 2007. Inhibition of colon cancer cell growth and antioxidant activity of bioactive compounds from Poncirus trifoliata (L.) Raf. Bioorg Med Chem 15:4923-4932. (Pubitemid 46836831)
15. Jeong JC, Lee JW, Yoon CH et al. 2005. Stimulative effects of Drynariae Rhizoma extracts on the proliferation and differentiation of osteoblastic MC3T3-E1 cells. J Ethnopharmacol 96:489-495.
16. Johnell O, Kanis J. 2005. Epidemiology of osteoporotic fractures. Osteoporos Int 16(Suppl 2):S3-S7. (Pubitemid 46232115)
17. Khosla S, Westendorf JJ, Oursler MJ. 2008. Building bone to reverse osteoporosis and repair fractures. J Clin Invest 118:421-428. (Pubitemid 351206529)
18. Kim HJ, Bae YC, Park RW et al. 2002. Bone-protecting effect of safflower seeds in ovariectomized rats. Calcif Tissue Int 71:88-94. (Pubitemid 36934781)
19. Kim HM, Kim HJ, Park ST. 1999. Inhibition of immunoglobulin E production by Poncirus trifoliata fruit extract. J Ethnopharmacol 66:283-288. (Pubitemid 29287196)
20. Kim KW, Suh SJ, Lee TK et al. 2008. Effect of safflower seeds supplementation on stimulation of the proliferation, differentiation and mineralization of osteoblastic MC3T3-E1 cells. J Ethnopharmacol 115:42-49.
21. Kim TH, Hong JM, Shin ES et al. 2009. Polymorphisms in the Annexin gene family and the risk of osteonecrosis of the femoral head in the Korean population. Bone 45:125-131.
22. Kim YJ, Kwak CI, Gu YY et al. 2004. Annealing control primer system for identification of differentially expressed genes on agarose gels. Biotechniques 36:424-426, 428, 430 passim.
23. Leclerc N, Luppen CA, Ho VV et al. 2004. Gene expression profiling of glucocorticoid-inhibited osteoblasts. J Mol Endocrinol 33:175-193. (Pubitemid 39206356)
24. Lee HT, Seo EK, Chung SJ et al. 2005. Prokinetic activity of an aqueous extract from dried immature fruit of Poncirus trifoliata (L.) Raf. J Ethnopharmacol 102:131-136.
25. Lee IJ, Xu GH, Ju JH et al. 2008. 21-Methylmelianodiols from Poncirus trifoliata as inhibitors of interleukin-5 bioactivity in Pro-B cells. Planta Med 74:396-400.
26. Lee JH, Lee SH, Kim YS et al. 2009. Protective effects of neohesperidin and poncirin isolated from the fruits of Poncirus trifoliata on potential gastric disease. Phytother Res 23:1748-1753.
27. Lewiecki EM. 2009. Emerging drugs for postmenopausal osteoporosis. Expert Opin Emerg Drugs 14:129-144.
28. Lotinun S, Evans GL, Turner RT et al. 2005. Deletion of membranebound steel factor results in osteopenia in mice. J Bone Miner Res 20:644-652. (Pubitemid 40393073)
29. Mazziotti G, Angeli A, Bilezikian JP et al. 2006. Glucocorticoidinduced osteoporosis: an update. Trends Endocrinol Metab 17:144-149.
30. Olney RC. 2009. Mechanisms of impaired growth: effect of steroids on bone and cartilage. Horm Res 72(Suppl 1):30-35.
31. Park SH, Park EK, Kim DH. 2005. Passive cutaneous anaphylaxisinhibitory activity of flavanones from Citrus unshiu and Poncirus trifoliata. Planta Med 71:24-27.
32. Raisz LG. 2005. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115:3318-3325. (Pubitemid 43121814)
33. Ralston SH, de Crombrugghe B. 2006. Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev 20:2492-2506. (Pubitemid 44396835)
34. Sambrook P, Cooper C. 2006. Osteoporosis. Lancet 367:2010-2018. (Pubitemid 43867702)
35. Shim WS, Back H, Seo EK et al. 2009. Long-term administration of an aqueous extract of dried, immature fruit of Poncirus trifoliata (L.) Raf. suppresses body weight gain in rats. J Ethnopharmacol 126:294-299.
36. Shin TY, Oh JM, Choi BJ et al. 2006. Anti-inflammatory effect of Poncirus trifoliata fruit through inhibition of NF-kappaB activation in mast cells. Toxicol In Vitro 20:1071-1076. (Pubitemid 44067375)
37. Spreafico A, Frediani B, Francucci CM et al. 2008. Role of apoptosis in osteoporosis induced by glucocorticoids. J Endocrinol Invest 31:22-27.
38. Suh SJ, Yun WS, Kim KS et al. 2007. Stimulative effects of Ulmus davidiana Planch (Ulmaceae) on osteoblastic MC3T3-E1 cells. J Ethnopharmacol 109:480-485.
39. Takemura K, Sakashita N, Fujiwara Y et al. 2009. Class A scavenger receptor promotes osteoclast differentiation via the enhanced expression of receptor activator of NF-kappaB (RANK). Biochem Biophys Res Commun 391:1675-1680.
40. Teitelbaum SL. 2000. Bone resorption by osteoclasts. Science 289:1504-1508.
41. Theobald J, Smith PD, Jacob SM et al. 1994. Expression of annexin VI in A431 carcinoma cells suppresses proliferation: a possible role for annexin VI in cell growth regulation. Biochim Biophys Acta 1223:383-390. (Pubitemid 24300334)
42. Vila de Muga S, Timpson P, Cubells L et al. 2009. Annexin A6 inhibits Ras signalling in breast cancer cells. Oncogene 28:363-377.
43. Wong RW, Rabie AB. 2006. Systemic effect of crude extract from rhizome of Drynaria fortunei on bone formation in mice. Phytother Res 20:313-315.
44. Yi JM, Kim MS, Koo HN et al. 2004. Poncirus trifoliata fruit induces apoptosis in human promyelocytic leukemia cells. Clin Chim Acta 340:179-185.
45. Yun SI, Yoon HY, Jeong SY et al. 2009. Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3beta. J Bone Miner Metab 27:140-148.